| NCT ID | NCT03221244 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2016-06-02 |
| Primary Completion | 2027-09-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2016-06-02 with a primary completion date of 2027-09-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Problems with distraction are widespread in the 21st century, but for people with developmental delays or behavioral challenges they can have more damaging effects. For example, susceptibility to distraction is associated with worse school and social performance, lower high school graduation rates, and increased incidence of serious accidents. The investigators' goal is to improve understanding of distractibility and develop a targeted treatment. The proposed intervention is based on models of habituation, which is a term that means reduced physiological and emotional response to a stimulus (e.g. moving object, or loud noise, etc.) as it is seen repeatedly. The investigators use virtual reality technology to show study participants distracting stimuli repeatedly in a virtual classroom setting, and their hypothesis states that participants will improve attention in the face of distraction by training with this technology intervention. The virtual classroom setting is especially relevant for children who have significant challenges with distractibility, such as children with ADHD. This intervention will likely be effective in helping individuals with other clinical disorders and perhaps the general population as well.
Eligibility Criteria
Inclusion Criteria: * Significant (T score \>= 60) ratings of Cognitive Problems/Inattention or DSM Inattention scale scores on the Conners' Parent or Teacher Rating Scale-3 or Parent ADHD Rating Scale-IV (ADHD-RS) * Endorsement of 4 or more symptoms of inattention on a clinical psychiatric interview (e.g. Parent DISC, DICA, Kiddie-SADS, Mini-KID) * Comfortable using a computer * Full Scale IQ \> 80 Exclusion Criteria: * Psychosis (by parent report at phone screen), significant depression, autism (15 or \> on Social Communication Questionnaire (SCQ)), psychotic disorders, visual or hearing impairment or any other disorder that may interfere with task performance * It is in the investigator's opinion that it is not in the subject's best interest to continue * Subject is non-compliant with training schedule * Subjects on pharmacotherapy for ADHD at the time of enrollment will be excluded from Aims 3 and 4. * Subjects starting behavioral or psychological treatment for ADHD during the training phase of the study will be excluded
Contact & Investigator
Julie Schweitzer, PhD
PRINCIPAL INVESTIGATOR
UC Davis MIND Institute
Frequently Asked Questions
Who can join the NCT03221244 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03221244 currently recruiting?
Yes, NCT03221244 is actively recruiting participants. Contact the research team at hs-airlab@ucdavis.edu for enrollment information.
Where is the NCT03221244 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT03221244 clinical trial?
NCT03221244 is sponsored by University of California, Davis. The principal investigator is Julie Schweitzer, PhD at UC Davis MIND Institute. The trial plans to enroll 50 participants.